510(k) Report

510(k) · Cleared

Cleared

TandemLung Oxygenator

K153295510(k) TraditionalCleared Feb 26, 2016105-day reviewClass II21 CFR 870.4350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardiacassist, Inc. · DTZ Oxygenator, Cardiopulmonary Bypass

Cleared on Feb 26, 2016 as substantially equivalent to K072362 (Novalung GmbH, 2007) after a 105-day review. Its family tree reaches back 5 generations to 1993.

Decided
Feb 26, 2016
Review
105 days
Class
Class II
Product code
DTZ
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K932252 (1993). No later device cites it as a predicate yet.

  1. Root · 5 generations backK932252 Affinity Hollow Fiber OxygenatorAvecor Cardiovascular, Inc. · 1993
  2. 4 generations backK992559 Hollow Fiber Membrane Oygenator Quadrox Hmo 1010Jostra Bentley · 1999
  3. 3 generations backK030264 Quandrox Safeline Hollow Fiber Membrane Oxygenator, Model Hmo 2030Jostra AG · 2003
  4. 2 generations backK061628 Jostra Quadrox D Safeline Diffusion Membrane Oxygenator, Model Hmod…Maquet Cardiopulmonary, AG · 2006
  5. 1 generation backK072362 Novalung Surgical Lung Assist (Sla) Membrane LungNovalung GmbH · 2007
  6. This deviceK153295 TandemLung OxygenatorCardiacassist, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K932252Affinity Hollow Fiber OxygenatorAvecor Cardiovascular, Inc.1993—
−4K992559Hollow Fiber Membrane Oygenator Quadrox Hmo 1010Jostra Bentley1999—
−3K030264Quandrox Safeline Hollow Fiber Membrane Oxygenator, Model Hmo 2030Jostra AG2003—
−2K061628Jostra Quadrox D Safeline Diffusion Membrane Oxygenator, Model Hmod 2030Maquet Cardiopulmonary, AG2006—
−1K072362Novalung Surgical Lung Assist (Sla) Membrane LungNovalung GmbH2007—
0 (this device)K153295TandemLung OxygenatorCardiacassist, Inc.2016—
FIG. 1 — Lineage of K153295, 1993–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTZ device

  1. #1 K240934 Quantum Perfusion Blood Oxygenator ECC…score 14.3 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072362Novalung Surgical Lung Assist (Sla) Membrane Lung
Summary page 4
…ication Name: Oxygenator, Cardiopulmonary Bypass (21 CFR 870.4350, Product Code DTZ) Predicate Device Novalung sLA Membrane Lung (K072362). Device Description The TandemLung Oxygenator TLO consists of an injection molded exterior shell containing a bundle of Polyme…
Novalung GmbH2007—

Also cleared against K072362: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 3.5 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K072362.

How does its category compare?

All DTZ devices

DTZ Oxygenator, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · DTZ

2in 2025

2007: 42008: 32009: 92010: 22011: 42012: 92013: 92014: 52015: 92016: 32017: 22018: 32019: 52020: 52021: 52022: 22023: 52024: 32025: 22026 (partial year): 3
2007high 9 (2009) · low 2 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTZ

124in 2024

2007: 55 days median2008: 88 days median2009: 210 days median2011: 160 days median2012: 90 days median2013: 28 days median2014: 28 days median2015: 134 days median2016: 62 days median2018: 72 days median2019: 90 days median2020: 93 days median2021: 336 days median2023: 145 days median2024: 124 days median2026 (partial year): 137 days median
2007high 336 (2021) · low 28 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTZ

1in 2025

2007: 72008: 52010: 12011: 132012: 142014: 22016: 12018: 2, 2 Class I2019: 12020: 32021: 1, 1 Class I2022: 62025: 1
2007high 14 (2012) · low 0 (2009)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DTZ

976in 2025

2007: 1342008: 1052009: 522010: 1192011: 1902012: 2152013: 3462014: 7642015: 6582016: 4432017: 3882018: 3202019: 4892020: 4422021: 5952022: 5592023: 7382024: 5352025: 976
2007high 976 (2025) · low 52 (2009)2025

MAUDE reports naming product code DTZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074557134
20083885105
20099210052
20102—1119
2011416013190
201299014215
20139280346
20145282764
201591340658
20163621443
20172—0388
20183722 (2)320
20195901489
20205933442
202153361 (1)595
20222—6559
202351450738
202431240535
20252—1976
202631370—

What is it indicated for?

The TandemLung Oxygenator (TLO) is intended to be used for adult patients for extracorporeal circulation during cardiopulmonary bypass in the field of open-heart surgery. Within the indicated flow rates, blood is oxygenated and carbon dioxide is removed. The utilization period of this device is restricted to six hours.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K153295: TandemLung Oxygenator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K153295

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026